VIA EDGAR
June 16, 2020
Office of Healthcare and Insurance
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Attention: | Irene Paik | |
| Christie Wong | ||
| Angela Connell |
| Re: | Forma Therapeutics Holdings, Inc. | |
| Acceleration Request for Registration Statement on Form S-1 | ||
| File No. 333-238783 |
Dear Ms. Paik,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Forma Therapeutics Holdings, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 18, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Gabriela Morales-Rivera at (617) 570-1329. We also respectfully request that a copy of the written order from the Securities and Exchange Commission (the “Commission”) verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Gabriela Morales-Rivera, by facsimile to (617) 801-8858.
If you have any questions regarding this request, please contact Gabriela Morales-Rivera of Goodwin Procter LLP at (617) 570-1329.
Sincerely, |
FORMA THERAPEUTICS HOLDINGS, INC. |
/s/ Frank D. Lee |
| Frank D. Lee |
President and Chief Executive Officer |
cc: | Jeannette Potts, Forma Therapeutics Holdings, Inc. | |
Todd Shegog, Forma Therapeutics Holdings, Inc. | ||
William D. Collins, Esq., Goodwin Procter LLP | ||
Sarah Ashfaq, Esq., Goodwin Procter LLP |
